OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The objective of the study was to evaluate the efficacy and safety of OTX-DP (dexamethasone insert) 0.4 mg for intracanalicular use when placed in the canaliculus of the eyelid for the treatment of the signs and symptoms of chronic allergic conjunctivitis
Epistemonikos ID: fc9d6ebc946fab6da03030e6da6965fa05355c39
First added on: May 20, 2024